157 related articles for article (PubMed ID: 1452516)
1. Acquired circulating anticoagulants.
Kunkel LA
Hematol Oncol Clin North Am; 1992 Dec; 6(6):1341-57. PubMed ID: 1452516
[TBL] [Abstract][Full Text] [Related]
2. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
Arai M
Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
[TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulants in children.
Singh AK; Rao KP; Kizer J; Lazarchick J
Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic methodologies for circulating anticoagulants.
Exner T
Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
[TBL] [Abstract][Full Text] [Related]
5. Acquired coagulation inhibitor-associated bleeding disorders: an update.
Franchini M; Veneri D
Hematology; 2005 Dec; 10(6):443-9. PubMed ID: 16321808
[TBL] [Abstract][Full Text] [Related]
6. Immunologically generated circulating anticoagulants in humans.
Edwards RL; Wakem CJ
Surv Immunol Res; 1984; 3(1):64-9. PubMed ID: 6426006
[No Abstract] [Full Text] [Related]
7. [Circulating anticoagulants of the lupus type and pregnancy].
Edelman P
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(7):931. PubMed ID: 3146596
[No Abstract] [Full Text] [Related]
8. Acquired factor VIII inhibitor.
Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
[TBL] [Abstract][Full Text] [Related]
9. [Circulating anticoagulants. Clinical conditions of diagnosis].
Godeau P; Blétry O; Piette JC; Wechsler B
Rev Med Interne; 1985 Dec; 6(5):523-41. PubMed ID: 3938557
[No Abstract] [Full Text] [Related]
10. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.
Green D; Hougie C; Kazmier FJ; Lechner K; Mannucci PM; Rizza CR; Sultan Y
Thromb Haemost; 1983 Apr; 49(2):144-6. PubMed ID: 6408752
[No Abstract] [Full Text] [Related]
11. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors to clotting factors.
Sallah S
Ann Hematol; 1997; 75(1-2):1-7. PubMed ID: 9322677
[TBL] [Abstract][Full Text] [Related]
13. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII.
Pechet L; Snyder LM; Chesney C; Colman RW
Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947
[TBL] [Abstract][Full Text] [Related]
15. The management of factor VIII inhibitors in non-hemophilic patients.
Green D
Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
[TBL] [Abstract][Full Text] [Related]
16. [A study on evaluation of circulating anticoagulant in borderline cases].
Ishii K; Himizu M; Ono F; Yamamoto M; Kawai Y; Watanabe K; Iri H
Rinsho Byori; 1989 Dec; 37(12):1379-84. PubMed ID: 2515324
[TBL] [Abstract][Full Text] [Related]
17. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
Luo YY; Zhang GS
Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
[TBL] [Abstract][Full Text] [Related]
18. Acquired circulating anticoagulants in malignancy.
Kunkel LA
Semin Thromb Hemost; 1992; 18(4):416-23. PubMed ID: 1470928
[No Abstract] [Full Text] [Related]
19. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
Klare M; Möller T; Hanke P; Weller P; Seige K
Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of lupus anticoagulants.
Triplett DA
Semin Thromb Hemost; 1990 Apr; 16(2):182-92. PubMed ID: 2112783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
